Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Gefitinib × Clear all

NCT00113529 2011-08-29

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Phase 1/2 Completed

42 enrolled 35 charts

Carcinoma, Renal Cell